OL
TXG icon

Optas LLC’s 10x Genomics TXG Stock Holding History

Optas LLC’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$768K Sell
20,044
-4,171
-17% -$109K 0.11% 109
2026
Q1 		$514K Buy
24,215
+1,832
+8% +$36.6K 0.08% 159
2025
Q4 		$365K Buy
22,383
+8,906
+66% +$135K 0.06% 239
2025
Q3 		$158K Buy
13,477
+421
+3% +$5.49K 0.03% 383
2025
Q2 		$151K Buy
+13,056
New +$119K 0.03% 339

Other funds holding TXG

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FC
Financial Consulate Hunt Valley, Maryland $899M AUM 20.23% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return

Optas LLC's TXG Position: Q2 2026 in Review

Optas LLC reduced its 10x Genomics (TXG) stake by 17% in Q2 2026, selling an estimated $109K and leaving 20,044 shares worth $768K. The position accounts for 0.11% of the portfolio, ranked #109.

Optas LLC first reported a position in TXG in Q2 2025 and has held it in 5 quarters since. 52 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Optas LLC held 20,044 shares of 10x Genomics worth $768K as of Q2 2026.
  • Optas LLC sold 4,171 10x Genomics shares in Q2 2026, an estimated $109K.
  • 10x Genomics made up 0.11% of Optas LLC's portfolio in Q2 2026, its #109 holding.
  • Optas LLC first reported a position in 10x Genomics in Q2 2025 and has held it in 5 quarters since.
  • 52 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Optas LLC's 13F filing for Q2 2026, filed 21 Jul 2026.